Back
Speaker illustration

Professor Angelo Avogaro

PADOVA HOSPITAL, Padova (Italy)

Presentations

Glucose-lowering medication after myocardial infarction: how I would treat.

Event: ESC Congress 2022

Topic: Risk Factors and Prevention

Session: What the cardiologist must know: glucose-lowering medication after myocardial infarction in hospital and after discharge

Access
1
Thumbnail

Medical treatment in prediabetes to reduce CV risk and avoid transitioning to diabetes - What is the optimal choice?

Event: ESC Congress 2022

Topic: Diabetes and the Heart

Session: All you need to know about your prediabetic patient: making the diagnosis and reducing risk

Access
0
Thumbnail

Non SGLT2 Terapia nello SCC associato a diabete: ma i DDP4 - Non sono indicati.

Event: Heart Failure 2021

Topic: Chronic Heart Failure

Session: Non SGLT2 Terapia nello SCC associato a diabete: ma i DDP4 - Non sono indicati.

Access
0
Thumbnail

SGLT2 inhibitors: beyond their glucose-lowering effects.

Event: ESC Preventive Cardiology 2021

Topic: Lipids

Session: Dyslipidaemia and type 2 diabetes - the two ugly sisters

Access
0
Thumbnail

How should we balance the gluco-centric and the cardio-centric management of diabetes?

Event: ESC Congress 2020

Topic: Diabetes and the Heart

Session: Balancing Treatment Needs for Diabetic Patients with Cardiovascular Disease

Access
0
Thumbnail

ESC 365 is supported by

logo Novo Nordisk